ÂÜÀòÂÒÂ×

Carlo Russo is a biotech executive with vast experience in research & development in large pharma companies, including GSK, Merck and Biotech. He has served as Head of Development of GSK’s R&D Biopharm and Rare Disease Units, the Head of Cardiovascular Metabolic Center and the founder & Head of the Alternative Development Programs. He was Executive VP and CMO of Adverum, CMO & Head R&D of Annapurna and President and CEO of VaxInnate Corporation, among other senior roles. Carlo holds a number of senior positions at research institutions, including Cornell University Medical College, Columbia University and Scripps Research Institute. He holds his MD and Board Certification in Hematology from the University of Genoa Medical School and is the author of more than 70 scientific publications.